A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer

被引：0
作者：
Brooks, Gabriel [6 ]
Borges, Virginia
Singh, Meenakshi [5 ]
Rabinovitch, Rachel [4 ]
Finlayson, Christina [3 ]
Elias, Anthony [1 ,2 ]
机构：
[1] Univ Colorado, Ctr Canc, Div Med Oncol, Sch Med, Aurora, CO 80045 USA
[2] Univ Colorado, Breast Canc Res Program, Sch Med, Aurora, CO 80045 USA
[3] Univ Colorado, Sch Med, Dept Surg, Aurora, CO 80045 USA
[4] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA
[5] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA
[6] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA
来源：
ONCOLOGY-NEW YORK | 2008年 / 22卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1270 / 1276
页数：7
相关论文
共 39 条
  • [11] Reduction in new metastases in breast cancer with adjuvant clodronate treatment
    Diel, IJ
    Solomayer, EF
    Costa, SD
    Gollan, C
    Goerner, R
    Wallwiener, D
    Kaufmann, M
    Bastert, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) : 357 - 363
  • [12] The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast - A fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study
    Downs-Kelly, E
    Yoder, BJ
    Stoler, M
    Tubbs, RR
    Skacel, M
    Grogan, T
    Roche, P
    Hicks, DG
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1221 - 1227
  • [13] Elledge RM, 2000, INT J CANCER, V89, P111, DOI 10.1002/(SICI)1097-0215(20000320)89:2<111::AID-IJC2>3.3.CO
  • [14] 2-N
  • [15] Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
    Fyles, AW
    McCready, DR
    Manchul, LA
    Trudeau, ME
    Merante, P
    Pintilie, M
    Weir, LM
    Olivotto, IA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (10) : 963 - 970
  • [16] GNANT M, 2008, J CLIN ONCOL S, V26, pS6
  • [17] Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
    Goldhirsch, A.
    Wood, W. C.
    Gelber, R. D.
    Coates, A. S.
    Thuerlimann, B.
    Senn, H.-J.
    Members, Panel
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (07) : 1133 - 1144
  • [18] Hanrahan EO, 2007, J CLIN ONCOL, V25, P4952, DOI 10.1200/JCO.2006.08.0499
  • [19] American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
    Hillner, BE
    Ingle, JN
    Chlebowski, RT
    Gralow, J
    Yee, GC
    Janjan, NA
    Cauley, JA
    Blumenstein, BA
    Albain, KS
    Lipton, A
    Brown, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) : 4042 - 4057
  • [20] Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    Howell, A
    Cuzick, J
    Baum, M
    Buzdar, A
    Dowsett, M
    Forbes, JF
    Hoctin-Boes, G
    Houghton, I
    Locker, GY
    Tobias, JS
    [J]. LANCET, 2005, 365 (9453) : 60 - 62
1234